Population Carrier Screening for Spinal Muscular Atrophy A Position Statement of the Association for Molecular Pathology

被引：20

作者：

Muralidharan, Kasinathan ^{[2
,3
]}

Wilson, Robert B. ^{[2
,4
]}

Ogino, Shuji ^{[2
,5
]}

Nagan, Narasimhan ^{[2
,6
]}

Curtis, Christine ^{[2
,7
]}

Schrijver, Iris ^{[1
,2
,8
]}

机构：

[1] Stanford Univ, Dept Pathol, Med Ctr, Sch Med, Stanford, CA 94305 USA

[2] Assoc Mol Pathol AMP, Clin Practice Comm, Chantilly, VA USA

[3] Quest Diagnost Nichols Inst, Chantilly, VA USA

[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

[6] Genzyme Corp, Mol Diagnost Lab, Westborough, MA USA

[7] Univ Hosp Cleveland, Ctr Human Genet Lab, Case Med Ctr, Cleveland, OH 44106 USA

[8] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2011年 / 13卷 / 01期

关键词：

ALLELE; SMN1;

D O I：

10.1016/j.jmoldx.2010.11.012

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Spinal muscular atrophy is a common and of ten fatal autosomal recessive disorder for which carrier screening is available. The Association for Molecular Pathology has evaluated recent opinions regarding population carrier screening, reviewed the current literature, and developed a position statement that includes specific recommendations addressing both diagnostic and;practical issues that affect implementation. (J Mol Diagn 2011, 13: 3-6; DOI: 10.1016/j.jmoldx.2010.11.012)

引用

页码：3 / 6

页数：4

共 50 条

[11] False Negative Carrier Screening in Spinal Muscular Atrophy
Butcher, Sophie
Smith, Melanie
Woodcock, Ian R.
Delatycki, Martin
Ryan, Monique M.
Forbes, Robin
JOURNAL OF CHILD NEUROLOGY, 2020, 35 (04) : 274 - 277
[12] Spinal muscular atrophy: population-based carrier screening by quantitive-PCR method
Al Jumah, M
Majumbar, R
Al Rajeh, S
Eyaid, W
Fetaini, N
Rehana, Z
Al Khalaf, H
JOURNAL OF NEUROLOGY, 2005, 252 : 85 - 85
[13] Carrier screening of spinal muscular atrophy in North Indian population and its public health implications
Verma, Ishwar C.
Kohli, Sudha
Shenbagam, Shruti
Bijarnia-Mahay, Sunita
DuaPuri, Ratna
Saxena, Renu
CLINICAL GENETICS, 2020, 98 (02) : 198 - 199
[14] Reversible molecular pathology of skeletal muscle in spinal muscular atrophy
Mutsaers, Chantal A.
Wishart, Thomas M.
Lamont, Douglas J.
Riessland, Markus
Schreml, Julia
Comley, Laura H.
Murray, Lyndsay M.
Parson, Simon H.
Lochmueller, Hanns
Wirth, Brunhilde
Talbot, Kevin
Gillingwater, Thomas H.
HUMAN MOLECULAR GENETICS, 2011, 20 (22) : 4334 - 4344
[15] Evaluating the performance of four assays for carrier screening of spinal muscular atrophy
Tan, Jianxin
Zhang, Jingjing
Sun, Ruihong
Jiang, Zhu
Wang, Yuguo
Ma, Dingyuan
Jiao, Jiao
Chen, Hao
Lin, Yingchun
Zhang, Qinxin
Xu, Zhengfeng
Hu, Ping
CLINICA CHIMICA ACTA, 2023, 548
[16] Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy
Burns, Joseph K.
Kothary, Rashmi
Parks, Robin J.
NEUROMUSCULAR DISORDERS, 2016, 26 (09) : 551 - 559
[17] Screening for spinal muscular atrophy
Sampaio, Hugo
Wilcken, Bridget
Farrar, Michelle
MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (04) : 147 - +
[18] A pilot study of spinal muscular atrophy carrier screening in Saudi Arabia
Al Jumah, Mohammed
Majumdar, Ramanath
Rehana, Zahra
Al Rajeh, Saad
Eyaid, Wafaa
JOURNAL OF PEDIATRIC NEUROLOGY, 2007, 5 (03) : 221 - 224
[19] Impact of a national population-based carrier-screening program on spinal muscular atrophy births
Aharoni, Sharon
Nevo, Yoram
Orenstein, Naama
Basel-Salmon, Lina
Ben-Shachar, Shay
Mussaffi, Huda
Sagi-Dain, Lena
Cohen, Rony
Singer, Amihood
NEUROMUSCULAR DISORDERS, 2020, 30 (12) : 970 - 974
[20] The impact of the national population carrier screening program on reducing birth rates of patients with spinal muscular atrophy
Aharoni, S.
Nevo, Y.
Orenstein, N.
Basel-Vanagaite, L.
Mussaffi, H.
Singer, A.
NEUROMUSCULAR DISORDERS, 2017, 27 : S137 - S137

← 1 2 3 4 5 →